MedPath

LUMBAR & SACROILIAC FUSION STUDY

Not Applicable
Recruiting
Conditions
Fusion of Spine
Sacroiliac; Fusion
Registration Number
NCT07204288
Lead Sponsor
Spinal Simplicity LLC
Brief Summary

This study is a multi-center, observational, prospective and retrospective data collection study

Detailed Description

The purpose of this study is to evaluate fusion outcomes and patient-reported outcomes for Spinal Simplicity's lumbar and/or sacroiliac fusion implants: the Minuteman G5 MIS fusion plate, the Liberty sacroiliac fusion device, and/or the Patriot sacroiliac fusion device. This will involve identifying patients previously implanted with any of these devices and conducting both retrospective and prospective data collection/analysis.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. Be 18 years of age or older at the time of enrollment
  2. Be willing and able to provide informed consent and comply with study visit requirements
  3. Subjects who received a Spinal Simplicity fusion implant(s) (Minuteman G5, Liberty, and/or Patriot) between April 1, 2022 and March 31, 2025
Exclusion Criteria
  1. Unable to provide consent and complete prospective data collection
  2. Women who are pregnant, or may become pregnant, during the course of the study
  3. Contraindication to CT scanning, in the opinion of the investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Investigate radiographic outcomesEnrollment

The primary endpoints include the rate of fusion, and the rate of complications or reoperations.

Fusion Scale:1) Radiographically evaluate the rate of fusion, as determined by a panel of independent radiologists per the below fusion assessment metrics: Lumbar fusion grading scale (Minuteman G5): 1- Definitely fused 2- Probably fused 3- Probably not fused 4- Definitely not fused;

Sacroiliac fusion assessment (Liberty, Patriot):

Device(s) will be evaluated for (i) the presence of bridging bone from ilium to sacrum; and (ii) any evidence of migration or loosening

Additionally, if Minuteman G5 subjects have an interbody fusion device, interbody fusion will be assessed using the Bridwell scale:

1- Definite fusion 2- Probable fusion 3- Intermediate fusion/possible motion 4- Pseudoarthrosis/no bony connection

Secondary Outcome Measures
NameTimeMethod
NRS/ Numeric Rating ScaleEnrollment

1\. Pain (Overall, Back and Leg) using NRS/numeric rating scale Overall pain, as well as back pain when standing/walking and leg pain when standing will be assessed using a numeric rating scale (NRS). The NRS is a pain screening tool, commonly used to assess pain severity at that moment in time using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable.

ODI/ Oswestry Disability IndexEnrollment

Oswestry Disability Index (ODI) ODI is a self-reported questionnaire widely used to track changes in a patient's condition over time and evaluate the effectiveness of treatments for low back pain. The ODI consists of 10 sections, each addressing a specific aspect of daily functioning. A higher score indicates greater disability. The final score/index ranges from 0-100 scale. A score of 0-20 reflects minimal disability, 21-40 moderate disability, 41-60 severe disability, 61-80 crippled, and 81-100 bed bound.

PGIC/ Patient Global Impression of ChangeEnrollment

The Patient Global Impression of Change (PGIC) PGIC is a standardized tool designed to assess a patient's self-reported perception of improvement or worsening in their health status over time. The PGIC consists of 1 question, using a 1 to 7 scale: 1-Very Much Improved to 7-Very much Worse.

Subject Satisfaction SurveyEnrollment

Subject Satisfaction Survey Subject Satisfaction Survey is made up of 8 questions designed to assess a patient's self-reported satisfaction or dissatisfaction on a Likert scale. The Likert scale consists of 8 questions individually scored on a 1 to 5 scale: With lower scores indicating higher satisfaction and higher scores indicating greater dissatisfaction.

Trial Locations

Locations (3)

Crimson Pain Management

🇺🇸

Overland Park, Kansas, United States

Nuroscience Research Center

🇺🇸

Overland Park, Kansas, United States

Nura Precision Pain Management

🇺🇸

Edina, Minnesota, United States

Crimson Pain Management
🇺🇸Overland Park, Kansas, United States
Morteza Rabii, NP
Contact
Daniel Kloster, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.